Patent directory · USPTO A61K / A61P
Patents matching “Almirall, S.A.”
71 pharma patents match "Almirall, S.A." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 71 pharmaceutical patents matching "Almirall, S.A." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9315463
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 9254262
Dosage and formulation
granted -
US 9233108
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 9206183
Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors
granted -
US 9133200
Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors
granted -
US 9108918
Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate
granted -
US 9056100
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 9034311
Pyridin-2(1 H)-one derivatives as JAK inhibitors
granted -
US 8865728
Combinations comprising methotrexate and DHODH inhibitors
granted -
US 8802699
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 8772288
Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors
granted -
US 8563731
Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
granted -
US 8536165
Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
granted -
US 8524908
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
granted -
US 8513279
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 8501943
Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
granted -
US 8450341
Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
granted -
US 8420669
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor
granted -
US 8334294
4,8-diphenyl-polyazanaphthalene derivatives
granted -
US 8283342
Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
granted -
US 8258308
Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
granted -
US 8258122
3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
granted -
US 8242177
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
granted -
US 8178679
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors
granted